Salusin肽α(SALa)多克隆抗體
Polyclonal Antibody to Salusin Alpha (SALa)
- 編號PAB892Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 CPB892Hu21-Salusin肽α(SALa)卵白蛋白偶聯(lián)物
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 598 ¥ 1394 ¥ 1992 ¥ 4980 ¥ 19920
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對SALa的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別SALa。
用法
Western blotting: 0.5-2μg/mL;1:100-400
Immunohistochemistry: 5-20μg/mL;1:10-40
Immunocytochemistry: 5-20μg/mL;1:10-40
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB892Hu01 | Salusin肽α(SALa)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPB892Hu11 | Salusin肽α(SALa)牛血清白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
CPB892Hu21 | Salusin肽α(SALa)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAB892Hu01 | Salusin肽α(SALa)多克隆抗體 | WB; IHC; ICC; IP. |
PAB892Hu08 | Salusin肽α(SALa)多克隆抗體 | WB; IHC; ICC; IP. |
CEB892Hu | Salusin肽α(SALa)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB892Hu | Salusin肽α(SALa)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB892Hu11 | Salusin肽α(SALa)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Peptides | The bioactive peptides salusins and apelin–36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass [PubMed: 22884920] |
Department of Medical Biochemistry and Clinical Biochemistry | Presence of adropin, nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows [ScienceDirect: S0196978113000533] |
European Journal of Obstetrics & Gynecology and Reproductive Biology | Association of low maternal levels of salusins with gestational diabetes mellitus and with small-for-gestational-age fetuses. [PubMed: 23178004] |
Biotechnic & Histochemistry | Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome [Pubmed: 23957705] |
Peptides | Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus [ScienceDirect: S0196978113003100] |
Med Sci Monit. | Brain, Liver, and Serum Salusin-alpha and-beta Alterations in Sprague-Dawley Rats with or Without Metabolic Syndrome [Pubmed:Pmc4136931] |
Pediatr Nephrol. | Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? [Pubmed:25245503] |
European Journal of Dermatology | Serum salusin-α and salusin-β levels in patients with psoriasis [PubMed: 26055619] |
Gynecol Endocrinol | Serum salusins levels are increased and correlated positively with cyst size in ovarian endometrioma [PubMed: 26008602] |
Multiple Sclerosis and?Related?Disorders | Increased level of Plasma Salusin-α and Salusin-β in patients with Multiple Sclerosis [Pubmed: 30738876] |
cardiology in the young | Salusin-α levels are negatively correlated with diastolic blood pressure in children with obesity [Pubmed: 31486354] |
Drug and Chemical Toxicology | Salusin-α mitigates diabetic nephropathy via inhibition of the Akt/mTORC1/p70S6K signaling pathway in diabetic rats [Pubmed: 31665937] |
Journal of international medical research | Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis [Pubmed: 32054363] |
J Ultrasound Med | Targeted Delivery of Salusin?\|á into Rabbit Carotid Arterial Endothelium Using SonoVue [33818784] |
Food Science & Nutrition | Inhibition of oxidative stress and apoptosis by camel milk mitigates cyclosporine?\induced nephrotoxicity: Targeting Nrf2/HO?\1 and AKT/eNOS/NO pathways [34136182] |
留言咨詢